Ra Medical Systems Stock Fundamentals

RMEDDelisted Stock  USD 0.68  0.02  2.86%   
RA Medical Systems fundamentals help investors to digest information that contributes to RA Medical's financial success or failures. It also enables traders to predict the movement of RMED Stock. The fundamental analysis module provides a way to measure RA Medical's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to RA Medical stock.
  
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

RA Medical Systems Company Return On Equity Analysis

RA Medical's Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.

Return On Equity

 = 

Net Income

Total Equity

More About Return On Equity | All Equity Analysis

Current RA Medical Return On Equity

    
  -3.25  
Most of RA Medical's fundamental indicators, such as Return On Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, RA Medical Systems is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
Competition

Based on the latest financial disclosure, RA Medical Systems has a Return On Equity of -3.2525. This is 86.43% lower than that of the Health Care Equipment & Supplies sector and 62.74% lower than that of the Health Care industry. The return on equity for all United States stocks is notably higher than that of the company.

RA Medical Systems Fundamental Drivers Relationships

Comparative valuation techniques use various fundamental indicators to help in determining RA Medical's current stock value. Our valuation model uses many indicators to compare RA Medical value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across RA Medical competition to find correlations between indicators driving RA Medical's intrinsic value. More Info.
RA Medical Systems is rated below average in return on equity category among its peers. It is rated below average in return on asset category among its peers . Comparative valuation analysis is a catch-all technique that is used if you cannot value RA Medical by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.

RMED Return On Equity Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses RA Medical's direct or indirect competition against its Return On Equity to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of RA Medical could also be used in its relative valuation, which is a method of valuing RA Medical by comparing valuation metrics of similar companies.
RA Medical is currently under evaluation in return on equity category among its peers.

RMED Fundamentals

About RA Medical Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze RA Medical Systems's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of RA Medical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of RA Medical Systems based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Ra Medical Systems, Inc., a medical device company, develops, manufactures, and markets excimer lasers for use in the treatment of vascular immune-mediated inflammatory diseases. Ra Medical Systems, Inc. was incorporated in 2002 and is headquartered in Carlsbad, California. Ra Medical operates under Medical Devices classification in the United States and is traded on AMEX Exchange. It employs 58 people.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income.
You can also try the Fundamentals Comparison module to compare fundamentals across multiple equities to find investing opportunities.

Other Consideration for investing in RMED Stock

If you are still planning to invest in RA Medical Systems check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the RA Medical's history and understand the potential risks before investing.
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Bonds Directory
Find actively traded corporate debentures issued by US companies